Physician profile
Mitchell J Isaac
NPI 1790213973
$543.21
in general payments reported to CMS, 2019-2025
9 companies · $168 in 2025
The $168 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $55.27 · 2023: $305 · 2024: $14.06 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $488.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $487.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $161.34 | 2023 | Restrata Wound Matrix |
| Glaxosmithkline, LLC. | $115.15 | 2022-2025 | Nucala |
| Novartis Pharmaceuticals Corporation | $91.11 | 2023 | |
| Stryker Corporation | $67.24 | 2022-2025 | Xpress Loprofile |
| Olympus America INC. | $31.59 | 2023 | Olympus |
| Kerecis Limited | $28.49 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Medtronic, INC. | $17.10 | 2025 | Propel |
| Phathom Pharmaceuticals, INC. | $16.76 | 2024-2025 | Voquezna |
| Inspire Medical Systems, INC. | $14.43 | 2025 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Isaac listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.